Cargando…

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

BACKGROUND: Melanoma brain metastasis is associated with an extremely poor prognosis, with a median overall survival of 4–5 months. Since 2011, the overall survival of patients with stage IV melanoma has been significantly improved with the advent of new targeted therapies and checkpoint inhibitors....

Descripción completa

Detalles Bibliográficos
Autores principales:	Vosoughi, Elham, Lee, Jee Min, Miller, James R., Nosrati, Mehdi, Minor, David R., Abendroth, Roy, Lee, John W., Andrews, Brian T., Leng, Lewis Z., Wu, Max, Leong, Stanley P., Kashani-Sabet, Mohammed, Kim, Kevin B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924486/ https://www.ncbi.nlm.nih.gov/pubmed/29703161 http://dx.doi.org/10.1186/s12885-018-4374-x

Ejemplares similares

Nanometer-scale distribution of PD-1 in the melanoma tumor microenvironment
por: Comerci, Colin J, et al.
Publicado: (2023)

The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
por: Dar, Altaf A., et al.
Publicado: (2015)

Complete clinical response to intralesional talimogene laherparepvec injection in a patient with recurrent, regionally advanced Merkel cell carcinoma
por: Nguyen, Michael H.K., et al.
Publicado: (2019)

Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration
por: Bezrookove, Vladimir, et al.
Publicado: (2013)

Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases
por: Ruschulte, Heiner, et al.
Publicado: (2013)

Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma
por: Miller, James R., et al.
Publicado: (2023)

The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression
por: Dar, Altaf A, et al.
Publicado: (2013)

Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients
por: Balkin, Daniel M., et al.
Publicado: (2023)

Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma
por: Dar, Altaf A., et al.
Publicado: (2022)

Natural history of pain associated with melanoma surgery
por: Slagelse, Charlotte, et al.
Publicado: (2018)

BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target
por: Bezrookove, Vladimir, et al.
Publicado: (2022)

The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
por: Marco, Tucci, et al.
Publicado: (2019)

Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
por: Rieth, John M., et al.
Publicado: (2021)

Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery
por: Leong, Stanley P., et al.
Publicado: (2018)

A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma
por: Minor, David R., et al.
Publicado: (2022)

Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
por: Phan, Binh, et al.
Publicado: (2016)

Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapies
por: Ice, Ryan J., et al.
Publicado: (2019)

CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
Publicado: (2019)

Comparing Melanoma Invasiveness in Dermatologist- versus Patient-Detected Lesions: A Retrospective Chart Review
por: Lamerson, Cindy L., et al.
Publicado: (2012)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication Stress
por: Bezrookove, Vladimir, et al.
Publicado: (2021)

Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment
por: Sidorov, Maxim, et al.
Publicado: (2023)

The Abscopal Effect in the Era of Checkpoint Inhibitors
por: Kodet, Ondřej, et al.
Publicado: (2021)

Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021)

Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma
por: Amaria, Rodabe N., et al.
Publicado: (2018)

Correlation Between Tumor-Associated Macrophage and Immune Checkpoint Molecule Expression and Its Prognostic Significance in Cutaneous Melanoma
por: Kim, Young Jae, et al.
Publicado: (2020)

Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies
por: Zoga, Eleni, et al.
Publicado: (2022)

The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
por: Hsu, Hsiao-Mei, et al.
Publicado: (2023)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

Diffuse granulomatous panniculitis associated with anti PD-1 antibody therapy
por: Jiang, Baijia, et al.
Publicado: (2017)

Gastric Cancer in the Era of Immune Checkpoint Blockade
por: Figueroa-Protti, Lucía, et al.
Publicado: (2019)

Management of hepatitis B in the era of checkpoint inhibition
por: Dutcher, Janice
Publicado: (2020)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma
por: Melin, Audrey, et al.
Publicado: (2022)

A case report: metastasis of melanoma to the heart in an era of immunotherapy
por: Poulsen, Christian B, et al.
Publicado: (2019)

Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2022)

Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
por: Byun, Hwa Kyung, et al.
Publicado: (2021)

Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
por: Saqub, Hera, et al.
Publicado: (2020)

Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors
por: Karaki, Soumaya, et al.
Publicado: (2016)

Perspective: cancer vaccines in the era of immune checkpoint blockade
por: Cebon, Jonathan
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rp91dv2rntbfjbtb6laqhe6e0h